Answers are grounded in this paper and cite their sources.
Case report highlights succinylcholine apnea following rivastigmine treatment, indicating important drug interactions.
Succinylcholine is widely used in anesthesia for electroconvulsive therapy (ECT). Succinylcholine apnea is a recognized rare complication. A patient’s dormant, undiagnosed, genetic pseudocholinesterase deficiency was clinically triggered and unmasked by the combination of long-term rivastigmine therapy and succinylcholine used in ECT, resulting in post-ictal succinylcholine apnea. In subsequent treatments, low-dose rocuronium was successfully used instead. Clinicians providing electroconvulsive therapy should consider potential interactions between cholinesterase-inhibiting drugs and succinylcholine or use alternative neuromuscular blocking drugs.
No takes yet. Share an insight, caveat, or question.
Ho et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: